Asset Management One’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.7M | Buy |
|
|||||
|
2025
Q2 | $22.6M | Buy |
|
|||||
|
2025
Q1 | $18.5M | Buy |
|
|||||
|
2024
Q4 | $15.6M | Sell |
|
|||||
|
2024
Q3 | $18.7M | Buy |
|
|||||
|
2024
Q2 | $16M | Sell |
|
|||||
|
2024
Q1 | $10.2M | Sell |
|
|||||
|
2023
Q4 | $13.6M | Buy |
|
|||||
|
2023
Q3 | $8.69M | Sell |
|
|||||
|
2023
Q2 | $9.38M | Buy |
|
|||||
|
2023
Q1 | $9.69M | Buy |
|
|||||
|
2022
Q4 | $11.4M | Sell |
|
|||||
|
2022
Q3 | $9.78M | Sell |
|
|||||
|
2022
Q2 | $7.51M | Buy |
|
|||||
|
2022
Q1 | $8.2M | Sell |
|
|||||
|
2021
Q4 | $8.9M | Sell |
|
|||||
|
2021
Q3 | $9.94M | Sell |
|
|||||
|
2021
Q2 | $8.97M | Sell |
|
|||||
|
2021
Q1 | $7.74M | Sell |
|
|||||
|
2020
Q4 | $7.16M | Sell |
|
|||||
|
2020
Q3 | $8.1M | Sell |
|
|||||
|
2020
Q2 | $8.63M | Sell |
|
|||||
|
2020
Q1 | $6.34M | Sell |
|
|||||
|
2019
Q4 | $6.88M | Buy |
|
|||||
|
2019
Q3 | $4.66M | Buy |
|
|||||
|
2019
Q2 | $3.56M | Sell |
|
|||||
|
2019
Q1 | $4.64M | Sell |
|
|||||
|
2018
Q4 | $10.2M | Sell |
|
|||||
|
2018
Q3 | $12.3M | Buy |
|
|||||
|
2018
Q2 | $13.7M | Buy |
|
|||||
|
2018
Q1 | $16.2M | Buy |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $3.94M | Buy |
|
|||||
|
2016
Q2 | $2.49M | Buy |
|
|||||
|
2016
Q1 | $404K | Hold |
|
|||||
|
2015
Q4 | $636K | Hold |
|
|||||
|
2015
Q3 | $527K | Hold |
|
|||||
|
2015
Q2 | $779K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $256K | Buy |
|